Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: placebo
Sponsors: Sanofi; Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified March 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days